Epone, France

Dominique Potin


Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 53(Granted Patents)


Location History:

  • Aubergenville, FR (1994 - 2004)
  • Epone, FR (2004 - 2008)

Company Filing History:


Years Active: 1994-2008

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dominique Potin

Introduction

Dominique Potin is a notable inventor based in Épône, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of 11 patents to his name, Potin's work has had a considerable impact on medical research and treatment options.

Latest Patents

Among his latest patents, Potin has developed pyrrolizine compounds that are useful as anti-inflammatory agents. These compounds are effective in treating inflammatory or immune diseases, characterized by specific chemical structures. Another significant invention is his spiro-cyclic compounds, which are also aimed at treating inflammatory and immune diseases. These compounds feature complex chemical formulas that enhance their therapeutic potential.

Career Highlights

Throughout his career, Dominique Potin has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bristol-Myers Squibb Company and Cerep SA. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Potin has collaborated with several esteemed colleagues, including Michele Launay and T G Murali Dhar. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Dominique Potin's contributions to the field of pharmaceuticals, particularly in anti-inflammatory agents, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to improving medical treatments and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…